, , , e.a.

Anticandidal Therapeutics

Discovery and Development

Specificaties
Paperback, blz. | Engels
Elsevier Science | 2023
ISBN13: 9780443187445
Rubricering
Elsevier Science e druk, 2023 9780443187445
Onderdeel van serie Developments in Microbiology
€ 173,80
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

Developments of antifungal agents have declined as compared to other antibiotics that have displayed a potent development with time. There is an urgent need for both prophylactic and therapeutic treatments worldwide to control the severity of infections caused by Candida. Anticandidal Therapeutics: Discovery and Development provides the readers with a compiled knowledge of the fungal human infection Candida and the development of anticandidal drugs. Anticandidal Therapeutics helps researchers form the basis for the discovery and development of novel anticandidal therapies. In 14 chapters this book provides collective information on anticandidal agents and their discovery and development with respect to major drug transporter families, different stages of anticandidal agent development, recent trends and progress in antifungal translational research, clinical studies status of anticandidal therapeutic agents, and drug repurposing for development of novel anticandidal agents.

Specificaties

ISBN13:9780443187445
Taal:Engels
Bindwijze:Paperback

Inhoudsopgave

<p>1. History of infection<br>2. Brief introduction on infection<br>3. Fungal diseases and antifungal drugs<br>4. Multidrug transporters of fungal pathogen Candida<br>5. Essential anticandidal targets<br>6. Stages of anticandidal agent development<br>7. Recent trends and progress in antifungal translational research<br>8. Clinical status of anticandidal therapeutic agents<br>9. Drug repurposing for development of effective anticandidals<br>10. Commercial aspects of drug development<br>11. Challenges and future prospects</p>
€ 173,80
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Anticandidal Therapeutics